LDS/Medical Tests/Glutamate Receptor Ionotropic Kainate 4 (GRIK4)

Glutamate Receptor Ionotropic Kainate 4 (GRIK4)

The glutamate receptor, ionotropic, kainate 4 (GRIK4) gene encodes the kainic acid-type glutamate receptor, a protein that belongs to the glutamate-gated ionic channel family. Glutamate functions as the major excitatory neurotransmitter in the central nervous system, as it is responsible for activation of ligand-gated ion channels and G protein-coupled membrane receptors.

Studies have shown that disturbance in the glutamate system is found in depression, bipolar disorder and schizophrenia. A genetic variant, rs1954787 of the GRIK4 gene, has been shown to be clinically important in antidepressant response and remission. Other studies have shown that gene variation rs1954787 (c.83-10039T>C) in the GRIK4 gene can be used to monitor response to citalopram. The C allele of rs1954787 variant was more frequent in depressive patients who responded to citalopram treatment than in non-responders. In a group of “Caucasian” patients, homozygous carriers of the C-allele had a 10% reduction of nonresponse relative to TT homozygote carriers (wild-type). The C allele occurs in 50% of Caucasians.

  • To monitor response to citalopram
  • To monitor depression drug response

83-10039TC, Reduced Response to citalopram

83-10039TT, Normal Response to citalopram

c.83-10039TT

Real-time Polymerase Chain Reaction (PCR), Sequencing, Pyrosequencing, PRC with ARMC or ASPE.

Whole blood collected in lavender top tube (EDTA) or any anticoagulant collection devices, Buccal swab. 

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
Drug toxicity testing if available, other CYP450 Gene Variations (CYP3A5, CYP2D6, CYPC9, CYPC19).
3-7 days
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login